Literature DB >> 29577172

Parafoveal and optic disc vessel density in patients with obstructive sleep apnea syndrome: an optical coherence tomography angiography study.

Laura Moyal1, Esther Blumen-Ohana2, Marc Blumen3,4, Cybele Blatrix2, Frederic Chabolle3, Jean-Philippe Nordmann2.   

Abstract

AIMS: To compare optic disc perfusion, radial peripapillary capillaries (RPC) and macular vascular density, between normal subjects and subjects with obstructive sleep apnea syndrome (OSAS) using spectral-domain OCT angiography (OCTA).
METHODS: Sixteen eyes of patients with mild OSAS, 17 eyes with moderate OSAS, 20 eyes with severe OSAS on polygraphy and 28 controls were evaluated with OCTA RT XR Avanti (AngioVue software, Optovue Inc., Fremont, CA). Optic nerve head (ONH), RPC and macular vessel density were measured. Clinical data, visual field parameters, and Spectral Domain OCT evaluation (retinal nerve fiber layer (RNFL) thickness and ganglion cell complex (GCC) thickness) were recorded for all patients.
RESULTS: ONH vascular flow (p = 0,396), RPC vascular density (automatized data "whole" p = 0,913, "peripapillary" p = 0,539, and segmented analysis with a topographic grid) and macular vascular density (foveal p = 0,484, parafoveal p = 0,491) were not significantly different between the four groups. FDT-Matrix™ and Humphrey 24/2 mean deviation were significantly lower in eyes with severe OSAS and were correlated to the apnea-hypopnea index. Retinal nerve fiber layer (RNFL) thickness, Cup/Disc ratio, rim area, and ganglion cell complex (GCC) were not significantly modified.
CONCLUSIONS: OCTA did not detect reduced ONH, RPC, neither macular blood vessel density in eyes with OSAS. The precise mechanisms that link OSAS with optic nerve pathologies remain unclear: our study was not able to demonstrate a vascular impact by OCTA examination.

Entities:  

Keywords:  FDT-Matrix; OCT angiography; Obstructive sleep apnea syndrome; Optic nerve; Vascularization; perimetry

Mesh:

Year:  2018        PMID: 29577172     DOI: 10.1007/s00417-018-3943-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  24 in total

1.  Swept-Source Optical Coherence Tomography Angiography and Vascular Perfusion Map Findings in Obstructive Sleep Apnea.

Authors:  Daniel Q Li; John Golding; Netan Choudhry
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2016-09-01       Impact factor: 1.300

2.  Obstructive sleep apnea/hypopnea syndrome increases glaucoma risk: evidence from a meta-analysis.

Authors:  Xinhua Wu; Huanbo Liu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms.

Authors:  A Barceló; M A Elorza; F Barbé; C Santos; L R Mayoralas; A G Agusti
Journal:  Eur Respir J       Date:  2001-04       Impact factor: 16.671

4.  Endothelial dysfunction and circulating microparticles from patients with obstructive sleep apnea.

Authors:  Pascaline Priou; Frédéric Gagnadoux; Angela Tesse; Maria Letizia Mastronardi; Abdelali Agouni; Nicole Meslier; Jean-Louis Racineux; Maria Carmen Martinez; Wojciech Trzepizur; Ramaroson Andriantsitohaina
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

5.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

6.  The Ocular Hypertension Treatment Study: design and baseline description of the participants.

Authors:  M O Gordon; M A Kass
Journal:  Arch Ophthalmol       Date:  1999-05

7.  Activation of the coagulation cascade in untreated primary open-angle glaucoma.

Authors:  C O'Brien; Z Butt; C Ludlam; P Detkova
Journal:  Ophthalmology       Date:  1997-04       Impact factor: 12.079

8.  Evaluation of choroidal thickness in patients with obstructive sleep apnea/hypopnea syndrome.

Authors:  Selcuk Kara; Muammer Ozcimen; Taha Tahir Bekci; Yasar Sakarya; Baran Gencer; Hasan Ali Tufan; Sedat Arikan
Journal:  Arq Bras Oftalmol       Date:  2014-09-01       Impact factor: 0.872

9.  Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea.

Authors:  K Palombi; E Renard; P Levy; C Chiquet; Ch Deschaux; J P Romanet; J L Pépin
Journal:  Br J Ophthalmol       Date:  2006-03-23       Impact factor: 4.638

Review 10.  Association between glaucoma and obstructive sleep apnea syndrome: a meta-analysis and systematic review.

Authors:  Yuhua Shi; Panpan Liu; Jian Guan; Yan Lu; Kaiming Su
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

View more
  14 in total

1.  Quantitative evaluation of retinal microvascular circulation in patients with obstructive sleep apnea-hypopnea using optical coherence tomography angiography.

Authors:  Yi Cai; Guo-Sheng Sun; Long Zhao; Fang Han; Ming-Wei Zhao; Xuan Shi
Journal:  Int Ophthalmol       Date:  2020-08-02       Impact factor: 2.031

Review 2.  Optical coherence tomography angiography-derived flow density: a review of the influencing factors.

Authors:  Viktoria C Brücher; Jens J Storp; Nicole Eter; Maged Alnawaiseh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-09       Impact factor: 3.117

Review 3.  Retinal microcirculation characteristics in obstructive sleep apnea/hypopnea syndrome evaluated by OCT-angiography: a literature review.

Authors:  Evita Evangelia Christou; Konstantinos Kostikas; Christoforos Asproudis; Paraskevas Zafeiropoulos; Maria Stefaniotou; Ioannis Asproudis
Journal:  Int Ophthalmol       Date:  2022-05-23       Impact factor: 2.031

4.  Optical coherence tomography angiography and Humphrey visual field in patients with obstructive sleep apnea.

Authors:  Arash Davanian; Lindsay Williamson; Caitlen Taylor; Abigail Harrover; Kathryn Bollinger; Bashir Chaudhary; Varsha Taskar; Tae Jin Lee; Yuhan Liu; Qingxia Chen; Dennis M Marcus
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

5.  Ganglion cell layer thickening in patients suffering from Obstructive Sleep Apnea-Hypopnea syndrome with long Mean Apnea-Hypopnea Duration during sleep.

Authors:  Evangelia Chalkiadaki; Konstantinos Andreanos; Efthymios Karmiris; Chrysoula Florou; Xanthi Tsiafaki; Anastasia Amfilochiou; Ilias Georgalas; Chrysanthi Koutsandrea; Dimitrios Papaconstantinou
Journal:  Int Ophthalmol       Date:  2020-11-17       Impact factor: 2.031

6.  Assessment of the Effectiveness of Obstructive Sleep Apnea Treatment Using Optical Coherence Tomography to Evaluate Retinal Findings.

Authors:  Gloria Tejero-Garcés; Francisco J Ascaso; Paula Casas; Maria I Adiego; Peter Baptista; Carlos O'Connor-Reina; Eugenio Vicente; Guillermo Plaza
Journal:  J Clin Med       Date:  2022-02-03       Impact factor: 4.241

7.  Retinal vascular impairment in patients newly diagnosed with obstructive sleep apnea syndrome.

Authors:  Tomás Loureiro; Sandra Rodrigues-Barros; Diogo Lopes; Ana Rita Carreira; Ricardo Gomes; Nadine Marques; Paula Telles; Ana Vide Escada; Nuno Campos
Journal:  Multidiscip Respir Med       Date:  2021-11-02

8.  Alterations in Parafoveal and Optic Disc Vessel Densities in Patients with Obstructive Sleep Apnea Syndrome.

Authors:  Turgay Ucak; Ethem Unver
Journal:  J Ophthalmol       Date:  2020-01-10       Impact factor: 1.909

9.  Retinal Vascular Changes in Patients with Chronic Obstructive Pulmonary Disease: An Optical Coherence Tomography Angiography Study.

Authors:  Abdurrahman Alpaslan Alkan; Eyup Duzgun; Murat Karapapak; Mufide Arzu Ozkarafakili; Ece Ozdemir Zeydanli; Gurcan Dogukan Arslan; Mehmet Egemen Karatas; Dilek Guven
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-07-04

10.  Normal tension glaucoma in obstructive sleep apnea syndrome: A structural and functional study.

Authors:  Lan-Hsin Chuang; Yeo-Yang Koh; Henry S L Chen; Yu-Lun Lo; Chung-Chieh Yu; Ling Yeung; Chi-Chun Lai
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.